Controls
Diasorin offers Simplexa™ Molecular and Process Controls for use in infectious disease molecular assays. Simplexa™ Process Controls are used to detect systemic variation that may arise during the extraction and amplification steps of real time PCR assays. Simplexa™ Molecular Controls are offered for a range of infectious disease targets.
Infectious disease
Product |
Description |
Code |
Volume/Quantity/Reactions |
|---|---|---|---|
| Simplexa™ Adenovirus Molecular Control |
Consists of inactivated adenovirus. |
MOL8011 |
2 x 250 µL |
| Simplexa™ BKV Molecular Control |
Consists of a DNA fragment of a well conserved region of BKV VP2 gene. |
MOL8009 |
2 x 250 µL |
| Simplexa™ Bordetella Molecular Control |
Consists of a 625 bp DNA fragment containing both the IS481 and IS1001 target regions. |
MOL8006 |
2 x 50 µL |
| Simplexa™ Bordetella Positive Control Pack |
Consists of inactivated Bordetella bacteria. |
MOL2760 |
10 |
| Simplexa™ C. auris Positive Control Pack |
Consists of inactivated Candida auris. |
MOL3960 |
10 |
| Simplexa™ C. difficile Positive Control Pack |
Consists of inactivated C. difficile bacteria. |
MOL2960 |
10 |
| Simplexa™ CMV Molecular Control |
Consists of a DNA fragment containing a well conserved region of CMV UL83 gene. |
MOL8002 |
2 x 250 µL |
| Simplexa™ Congenital CMV Positive Control Pack |
Consists of inactivated cytomegalovirus. |
MOL2260 |
10 |
| Simplexa™ COVID-19 Positive Control Pack |
Consists of synthetic gene fragments for SARS-CoV-2 ORF1ab and S gene target regions. |
MOL4160 |
10 |
| Simplexa™ COVID-19 & Flu A/B Positive Control Pack |
Consists of inactivated SARS-CoV-2 virus, inactivated influenza A virus and inactivated influenza B virus. |
MOL4260 |
10 |
| Simplexa™ COVID-19 / Flu A/B & RSV Positive Control Pack |
Consists of Inactivated SARS-CoV-2 virus, inactivated influenza A virus, inactivated influenza B virus, inactivated RSV virus. |
MOL4460 |
10 |
| Simplexa™ Dengue Molecular Control |
Consists of inactivated Dengue virus including serotypes 1, 2, 3, and 4. |
MOL3103C |
2 x 800 µL |
| Simplexa™ EBV Molecular Control |
Consists of a DNA fragment of a well conserved region of EBV LMP2A gene. |
MOL8008 |
2 x 250 µL |
| Simplexa™ Flu A/B & RSV Positive Control Pack |
Consists of inactivated influenza A virus, inactivated influenza B virus, and inactivated RSV. |
MOL2660 |
10 |
| Simplexa™ GBS Positive Control Pack |
Consists of inactivated Group B Streptococcus bacteria. |
MOL3560 |
10 |
| Simplexa™ Group A Strep Molecular Control |
Consists of inactivated Group A Streptococcus (GAS) bacteria. |
MOL8033 |
1 x 100 µL |
| Simplexa™ Group A Strep Positive Control Pack |
Consists of inactivated Group A Streptococcus (GAS) bacteria. |
MOL2860 |
10 |
| Simplexa™ HSV 1 & 2 Positive Control Pack |
Consists of inactivated HSV 1 & 2 viruses. |
MOL2160 |
10 |
| Simplexa™ SARS-CoV-2 Variants Positive Control Pack (RUO) |
Consists of inactivated SARS-CoV-2 viral particles. For research use only. Not for use in diagnostic procedures. |
MOL4360 |
10 |
| Simplexa™ VZV Positive Control Pack |
Consists of inactivated varicella-zoster virus. |
MOL3660 |
10 |
| Simplexa™ Extraction and Amplification Control Set |
This set consists of a DNA template and labeled primer pair intended to be used as a process control to detect systemic variation that may arise during the extraction and amplification steps of real-time polymerase chain reaction (PCR) assays. The set is not intended to monitor other real-time PCR processes. |
MOL9000 MOL9300 |
100 1000 |
| Simplexa™ Extraction and Amplification Control Set – RNA |
This set consists of a RNA template and a labeled primer pair intended to be used as a process control to detect systemic variation that may arise during the extraction and amplification steps of real-time reverse transcription polymerase chain reaction (RT-PCR) assays. The set is not intended to monitor other real-time PCR processes. |
MOL9200 |
100 |